ZENTEK LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.48 CAD | +2.07% |
|
+4.23% | +2.07% |
| 04-25 | Zentek Ltd. Provides ZenGUARD Business Update | CI |
| 04-03 | Zentek Ltd. Enters into Definitive Distribution Agreement with Medwell Solutions LLC | CI |
| Sales 2022 | 0.35 0.47 27.71 | Sales 2023 | 0.07 0.1 5.81 | Capitalization | 206M 281M 16.44B |
|---|---|---|---|---|---|
| Net income 2022 | -38M -51.88M -3.03B | Net income 2023 | -14M -19.11M -1.12B | EV / Sales 2022 | 1,031,593,065 x |
| Net cash position 2022 | 24.44M 33.37M 1.95B | Net cash position 2023 | 8.75M 11.94M 698M | EV / Sales 2023 | 2,707,984,696 x |
| P/E ratio 2022 |
-9.19
x | P/E ratio 2023 |
-14.3
x | Employees | 29 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.07% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.07% | ||
| 1 week | +4.23% | ||
| Current month | -8.64% | ||
| 1 month | -8.64% | ||
| 3 months | -11.90% | ||
| 6 months | -17.78% | ||
| Current year | +2.07% |
1 week
1.42
1.59
1 month
1.381.65
Current year
1.382.12
1 year
1.302.30
3 years
1.307.50
5 years
0.007.50
10 years
0.007.50
| Managers | Title | Age | Since |
|---|---|---|---|
Gregory Fenton
CEO | Chief Executive Officer | - | 10/07/18 |
Wendy Ford
DFI | Director of Finance/CFO | - | 15/05/22 |
Adam MacIntosh
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ilse Treurnicht
BRD | Director/Board Member | - | 04/07/22 |
John Snisarenko
BRD | Director/Board Member | 61 | 04/10/23 |
Francis Dubé
COO | Chief Operating Officer | - | 10/05/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 1.48 | +2.07% | 63,125 |
| 25/04/24 | 1.45 | -3.97% | 41,330 |
| 24/04/24 | 1.51 | -2.58% | 34,610 |
| 23/04/24 | 1.55 | 0.00% | 29,919 |
| 22/04/24 | 1.55 | +9.15% | 137,727 |
Delayed Quote Toronto S.E., April 26, 2024 at 08:59 pm
More quotes
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Companyâs developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
Calendar
28/08/2024
- Q1 2025 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.07% | 109M | |
| +1.51% | 42.75B | |
| +48.26% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- ZEN Stock
